Best Life Sciences Platforms and Tools Companies in Berlin, Germany
The 58 best Life Sciences Platforms and Tools companies in Berlin, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Caprotec.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Berlin
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 8sens.biognostic Developing and offering custom development and manufacturing services for POC Immunoassays | — | — | Unfunded | 9 | — | — | 8 patents Enzyme immunoassay kits using endogenous calibrators and signal‑generating capsule particles | — |
| 2 | Alrise Biosystems Developer of nano and microencapsulation drug delivery technology | — | — | Deadpooled | 9 | — | — | 37 patents Formulating drug‑loaded micro/nanoparticles for controlled release delivery systems. | — |
| 3 | Astra biotech Developer of in-vitro diagnostic reagents and kits | — | — | Unfunded | 4 | Jog Raj CEO & Director | PHPUNIXApache HTTP Server+5 | — | — |
| 4 | Bandelin Manufactures Ultrasound homogenizer | — | — | Unfunded | — | Wilhelm Bandelin Founder | Cart FunctionalityWooCommerceWordPress+38 | — | — |
| 5 | BBi-Biotech Develops fermentors and bioreactors | — | — | Unfunded | — | Bernd-Ulrich Wilhelm Owner | WordPress Block EditorWordPressMySQL+17 | — | — |
| 6 | BioTeZ Provider of life science products and services | — | — | Acquired | 20 | Uwe Ahnert CEO & Managing Director | — | — | — |
| 7 | CaloBox Developer of technology for animal behavioral analysis | — | — | Unfunded | — | York Winter CEO | — | — | — |
| 8 | Celares Develops drug delivery systems using PEGylation | — | — | Acquired | 25 | Guenther Paetz Co-Founder | — | 16 patents Advanced bioconjugate chemistries for multimeric, PEGylated drug-linker therapeutics | — |
Top 12 Life Sciences Platforms and Tools companies in Berlin
#1
Funding Raised · Berlin, Berlin · founded 2017$6.1Mraised▾
Developer of multiphoton tomography and fluorescence lifetime imaging microscopy technology. The company provides instruments for tissue imaging using femtosecond laser technology. These instruments offer high-resolution optical biopsies and metabolic images. The technology supports in vivo histology through two-photon fluorescence, SHG, and Raman signals. Applications include tissue pathology detection, skin ageing measurement, and analysis of biopsies.
- Jul 2021Grant (prize money)$464.9K
- Aug 2018Grant (prize money)$2.9M
- Sep 2016Grant (prize money)$2.8M
#2
Funding Raised · Berlin, Berlin · founded 2010 · 31 employees$2.3Mraised▾
Developer of a multi-organ chip platform for tissue culture. The company has HUMIMIC devices, chips, cells, and accessories that are based on the human-on-a-chip technology platform. It is a miniaturized construct that simulates the activity of multiple human organs used for toxicity, ADME profiles, and efficacy in vitro, reducing and replacing laboratory animal testing.
- Jun 2021Grant (prize money)$796K
- Mar 2021Grant (prize money)$602K
- Dec 2020Grant (prize money)$96.9K
- Mar 2019Grant (prize money)$17.2K
#3
Funding Raised · Berlin, Berlin · founded 2014 · 29 employees$974Kraised▾
Ospin focuses on developing scalable bioreactor platform which enables tissue production for a wide range of clinical and research applications and provides automation for many tissue models in parallel. Additionally, the company also manufactures metabolite monitors for real-time glucose, lactate, glutamine, and glutamate measurement.
- Mar 2021Grant (prize money)$549.9K
- Aug 2019Grant (prize money)$117.2K
- Feb 2019Grant (prize money)$94.9K
- Jan 2019Grant (prize money)$117.2K
#4
Funding Raised · Berlin, Berlin · founded 2009 · 20 employees$6.6Mraised▾
Alacris Theranostics is a genomics company providing NGS and data analysis services to scientists and clinicians. Alacris is an Illumina and Agilent certified service provider and provides the full range of NGS and related services from project planning to advanced data analysis. Is a part of an EU Flagship project called DigiTwins that is developing a digital twin technology for individualized healthcare and disease prevention of patients on the basis of the ‘virtual patient’ strategy.
- Jan 2019Grant (prize money)$987.3K
- Jan 2018Grant (prize money)$299.3K
- Mar 2016Grant (prize money)$4.1M
- Jan 2016Grant (prize money)$881.2K
#5
Acquired · Berlin, Berlin · founded 2000 · 114 employees$5.7Mraised▾
Scienion provides solutions for the genomics and proteomics industry. Its proprietary platform is a non-contact dispensing technology for microarray spotting. The company provides products like the sciFLEXARRAYER for automated handling of ultra low volume samples, the sciLINER for dispensing of ultra low volume samples and consumables for the same.
- Apr 2020Grant (prize money)$316.3K
- Jan 2020Grant (prize money)$322.2K
- Jul 2006Series A$5.7M
#6
Acqui-Hired · Berlin, Berlin · founded 2007 · 11 employees$15.3Mraised▾
Caprotec bioanalytics has developed a technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner. Caprotec’s Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecule probes that are used to target, capture, and isolate proteins based on their functionality. The company is commercializing the CCMS technology by running collaborative research for pharmaceutical and agrochemical companies.
- May 2011Series B$1.4M
- May 2010Series B$5.1M
- Jan 2008Series A$2.2M
- Nov 2007Series A$6.6M
#7
Acqui-Hired · Berlin, Berlin · founded 2004 · 7 employees$411.9Kraised▾
Cyano Biotech is a German biotech that develops therapeutic drugs and other applications from cyanobacteria. The company identifies and characterises natural products by screening cyanobacteria. They have developed 2 lines of products with potential therapeutic action: Microcystins as antitumor agents, and Microginins as ACE inhibitors. The company also offers its services to clients, notably in strains cultivation and biomass growth, extraction, fractionation, compound purification, etc.
- Sep 2020Grant (prize money)$206K
- Jan 2020Grant (prize money)$206K
#8
Seed · Berlin, Berlin · founded 2018 · 3 employees$1.4Mraised▾
Belyntic provides technology for purification and modification of chemically synthesized peptides. It offers HPLC-free peptide purification “Peptide Easy Clean” technology which is a catch & release technology. The company also offers its kits for research and developer which has set of 48 short peptides and can be used in the development and validation of LC-MS/MS quantification methods.
- Sep 2019Seed$1.4M
#9
Acqui-Hired · Berlin, Berlin · founded 2000$2.2Mraised▾
Combinature Biopharm was an R&D company focussed on the identification of genes for the synthesis of natural substances. It used high-throughput technologies of modern genome research to generate genome libraries of microorganisms and isolate specific novel genes for the biosynthesis of natural products from these libraries. It claims to have identified biosynthetic genes that are integrated into the genomes of other microorganisms which are known to produce pharmacologically active natural substances. It was in collaboration with Aventis Pharma. In 2006, MerLion Pharmaceuticals acquired Combinature Biopharm.
- 2006Series C—
- May 2006Series C$2.2M
#10
Funding Raised · Berlin, Berlin · founded 2000$888.6Kraised▾
Chemicell develops and produces bioseparation- gene transfection and detection systems based on magnetic nano- and microparticles. The company has ready use kits with a wide range of magnetic, and nanomagnetic particles such as nano-screenMAG, New fluidMAG-PEG/Amine magnetic nanoparticles, New PEG-Amine derivatives, ZeoliteMAG, and beadBALL.
- Apr 2016Grant (prize money)$455.7K
- Jan 2016Grant (prize money)$432.9K
#11
Funding Raised · Berlin, Berlin · founded 2014$289.8Kraised▾
CPO (Cell Phenomics and Oncology) is commercializing its patient-derived 3D cell culture (PD3D) platform for oncology research. PD3D cultures are novel multicellular systems freshly isolated from primary organs by mechanical and enzymatic dissociation. In this system, cells grown on a proprietary matrix grow as 3D organoids which are composed of cell clusters maintaining the complex composition of the tissue of origin. These structures are able to self-organize, preserving the original tissue architecture and marker expression. The company provides R&D services including in vitro toxicity assays, drug screening, and translational research services based around its PD3D platform.
- Oct 2019Grant (prize money)$289.8K
#12
Funding Raised · Berlin, Berlin · founded 2007$843.6Kraised▾
Provider of genomics research services. The company provides research services in genomics on high-throughput technology platforms such as microarrays, targeted sequence capture and next-generation sequencing. The company is a certified Affymetrix, Agilent and NimbleGen Service Provider, and its labs are ISO certified.
- Feb 2014Grant (prize money)$843.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Berlin is moving
A read on the academic research around Bioinformatics in Berlin — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 204 papers.
Charité, Humboldt, and Freie Universität Berlin lead 204 papers on single-cell transcriptomics and rare disease genomics, with a cautiously optimistic stance (mean 0.49).
- Charité - Universitätsmedizin Berlin95
- Humboldt-Universität zu Berlin46
- Freie Universität Berlin42
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin40
- Technische Universität Berlin16
- Gene1→4
- Disease8
- Immune system7
- Genetic association4
- Gene4
- Genome-wide association study3
- Disease5
- Genome3
- Firmicutes2
- Metadata2
- Proteomics2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.